Last reviewed: June 17, 2026

Last updated: June 17, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Weight loss with semaglutide varies significantly between individuals, with clinical trials showing average losses of 15–22% of baseline body weight over 68 weeks. Understanding realistic weekly targets and the biological factors driving your personal results helps set sustainable expectations and maintain motivation throughout GLP-1 therapy.

Typical Weekly Weight Loss During Semaglutide Treatment

Most patients on semaglutide experience 0.5–2 pounds of weight loss per week during the dose-escalation phase, which typically spans 16–20 weeks. This rate is significantly higher than standard diet-and-exercise approaches, which generally produce 1–2 pounds monthly. The rapid initial phase often plateaus once you reach your maintenance dose, at which point weekly losses may slow to 0.25–0.75 pounds as your body adapts to the medication's appetite-suppressing effects.

Weekly loss is not linear. Many patients report larger drops in weeks 1–4 after starting, partly due to reduced fluid retention and decreased caloric intake. Subsequent weeks often show more modest but steady declines. Some patients experience temporary plateaus lasting 2–4 weeks, which is a normal metabolic adaptation and not a sign that the medication has stopped working.

Factors That Influence Your Individual Weight Loss Rate

Your starting weight, age, sex, baseline metabolism, and physical activity level all shape how quickly semaglutide works. Patients with higher starting weights typically see faster absolute pound loss in early weeks, while those closer to goal weight may progress more slowly. Genetic variation in GLP-1 receptor expression—measured by markers like GLP1R rs6923761—contributes to how sensitively your body responds to the medication, directly affecting appetite suppression and weight trajectory.

Adherence to consistent dosing, adequate hydration, and protein intake are behavioral anchors that maximize results. Patients who experience more nausea or gastrointestinal side effects may reduce caloric intake more dramatically, accelerating weight loss initially but potentially risking lean muscle loss if protein needs aren't met. PlexusDx's Precision Peptide Genetic Test maps 14 metabolic pathways and identifies your genetic predispositions to GLP-1 response, helping personalize expectations based on your biology.

Clinical Trial Data: What the Research Shows

The STEP trials (Semaglutide Treatment Effect in People with obesity) documented average weight losses of 9.3 kg (20.5 lbs) at 68 weeks in the 2.4 mg weekly dose group, compared to 2.7 kg in the placebo group. Breaking this into weekly averages, participants lost approximately 0.3 pounds weekly over the full trial period, though losses were front-loaded in months 1–4. Real-world data from compounding pharmacies shows similar trends, with many patients achieving 15–25% total body weight reduction by 6 months.

Importantly, weight loss benefits are dose-dependent but not strictly linear—higher doses don't always produce proportionally larger losses in all patients. Some individuals reach an effective dose at 0.5–1.0 mg weekly and plateau there, while others benefit from escalation to 2.4 mg. The variability underscores why personalized assessment and genetic insights matter when optimizing your therapy.

Sustaining Weight Loss and Avoiding Plateaus

Plateaus during semaglutide treatment are expected and temporary. Your body adapts to reduced caloric intake over 4–8 weeks, after which baseline metabolic rate may dip slightly. Strategies to overcome plateaus include maintaining consistent exercise (both aerobic and resistance training to preserve muscle), increasing protein intake to 25–30% of daily calories, and ensuring adequate sleep and stress management. Some patients benefit from medication adjustments under medical supervision, though dose increases should be thoughtful and gradual.

Long-term weight loss maintenance with semaglutide depends on continued adherence. Studies indicate that weight regain occurs in most patients who discontinue the medication, emphasizing that GLP-1 therapy is an ongoing treatment rather than a short-term intervention. PlexusDx supports sustained results by offering consistent pricing—your dose may need adjustment, but your monthly cost remains stable—and access to the Precision Peptide Genetic Test to optimize your personalized protocol after your first month of treatment.

Comparing Semaglutide Injections and Oral Formulations

Compounded semaglutide injections typically produce slightly faster and more consistent weight loss than oral forms, because injectable delivery bypasses variable stomach absorption and delivers medication directly into subcutaneous tissue. Patients on injectable semaglutide often report weight loss within the 1–2 pounds-per-week range during dose escalation, while oral semaglutide users may see 0.5–1.5 pounds weekly, depending on meal timing and GI tolerance. PlexusDx offers both formats: injections starting at $149/month and oral formulations at $249/month.

Choice between injection and oral largely depends on personal preference, injection comfort, and whether gastrointestinal side effects are better managed with one route over the other. Both are compounded from licensed 503A pharmacies and carry the same efficacy potential when dosed equivalently. Your PlexusDx provider can help match you to the formulation most likely to support your lifestyle and weight loss goals.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is 1–2 pounds per week a safe and realistic target on semaglutide?

Yes. The 1–2 pounds-per-week range during dose escalation is both safe and typical for semaglutide users. This exceeds standard dietary weight loss (0.5–1 pound weekly) and reflects the medication's suppression of hunger hormones. Weight loss naturally slows as you approach maintenance dose, which is normal and sustainable.

Why does my weight loss slow down after a few weeks?

Metabolic adaptation occurs as your body adjusts to lower caloric intake. Additionally, once you stabilize at your therapeutic dose, the rate of loss often plateaus from its initial rapid phase. This is expected, not a failure of the medication. Continuing consistent dosing, protein intake, and exercise helps maintain steady progress.

Can PlexusDx help me understand my personal weight loss potential?

Absolutely. PlexusDx offers the Precision Peptide Genetic Test ($99 add-on after your first month) which analyzes 14 metabolic pathways and 150+ genetic insights, including GLP-1 receptor variants like rs6923761 that predict individual drug response. This personalization helps set realistic targets tailored to your biology. PlexusDx compounded semaglutide starts at $149/month with no insurance required.

Should I be concerned if my weekly loss fluctuates or plateaus?

Fluctuation and brief plateaus are normal and don't indicate treatment failure. Weight loss is not linear—some weeks may show larger drops than others due to hydration, hormonal cycles, and metabolic adaptation. Most patients experience 2–4 week plateaus during extended therapy; these typically resolve with continued adherence. Consult your provider if plateaus last longer than 6–8 weeks without any movement.

Does compounded semaglutide from PlexusDx produce the same weekly weight loss as brand-name Wegovy?

Yes. Compounded semaglutide from licensed 503A pharmacies contains the same active ingredient and produces equivalent weight loss when doses are matched. PlexusDx semaglutide injections start at $149/month, offering significant cost savings compared to brand alternatives, and are accessible in all 50 states without insurance requirements.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves